Checkpoint Therapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.65%40.350.9%$2406.88m
JNJJohnson & Johnson 0.83%150.240.7%$1152.56m
ABBVAbbVie, Inc. 2.42%107.271.9%$937.70m
MRKMerck & Co., Inc. 0.57%81.910.7%$681.87m
BMYBristol-Myers Squibb Co. 0.85%62.311.0%$627.96m
LLYEli Lilly & Co. 3.05%148.501.1%$611.14m
AZNAstraZeneca Plc 1.82%53.741.2%$375.21m
TTNPTitan Pharmaceuticals, Inc. -3.85%3.5017.1%$266.44m
GSKGlaxoSmithKline Plc 0.62%37.500.2%$214.98m
NVSNovartis AG 1.52%91.610.2%$191.99m
ARCTArcturus Therapeutics Holdings, Inc. 12.79%112.010.0%$146.59m
RGENRepligen Corp. 0.60%188.337.1%$92.93m
SBTXSilverback Therapeutics, Inc. 19.05%25.000.0%$88.29m
KNTEKinnate Biopharma, Inc. 11.35%43.460.0%$86.26m
NVONovo Nordisk A/S 0.89%67.810.1%$83.43m

Company Profile

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.